Landscape of Multidrug-Resistant Gram-Negative Infections in Egypt: Survey and Literature Review

References

• Eichenberger EM, Thaden JT. Epidemiology and mechanisms of resistance of extensively drug resistant Gram-negative bacteria. Antibiotics (Basel). 2019;8(2). doi:10.3390/antibiotics8020037
   Web of Science ®Google Scholar
• Poole K. Multidrug resistance in Gram-negative bacteria. Curr Opin Microbiol. 2001;4(5):500–508. doi:10.1016/S1369-5274(00)00242-311587924
   PubMed Web of Science ®Google Scholar
• Gaynes R, Edwards JR; National Nosocomial Infections Surveillance S. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41(6):848–854. doi:10.1086/43280316107985
   PubMed Web of Science ®Google Scholar
• Sartelli M, Catena F, Ansaloni L, et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study. World J Emerg Surg. 2014;9(1):37. doi:10.1186/1749-7922-9-3724883079
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Kaye KS, Pogue JM. Infections caused by resistant Gram-negative bacteria: epidemiology and management. Pharmacotherapy. 2015;35(10):949–962. doi:10.1002/phar.163626497481
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics; 2017. Available from: https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/. Accessed 1126, 2020.
   Google Scholar
• Codjoe FS, Donkor ES. Carbapenem resistance: a review. Med Sci (Basel). 2017;6(1). doi:10.3390/medsci6010001
   Google Scholar
• Corcione S, Lupia T, Maraolo AE, Mornese Pinna S, Gentile I, De Rosa FG. Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship. Curr Opin Infect Dis. 2019;32(6):663–673. doi:10.1097/QCO.000000000000059831599774
   PubMed Web of Science ®Google Scholar
• Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of infections due to MDR Gram-negative bacteria. Front Med (Lausanne). 2019;6:74. doi:10.3389/fmed.2019.0007431041313
   PubMed Web of Science ®Google Scholar
• Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589–601. doi:10.1016/S1473-3099(06)70580-116931410
   PubMed Web of Science ®Google Scholar
• Panidis D, Markantonis SL, Boutzouka E, Karatzas S, Baltopoulos G. Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia. Chest. 2005;128(2):545–552. doi:10.1378/chest.128.2.54516100136
   PubMed Web of Science ®Google Scholar
• Zusman O, Avni T, Leibovici L, et al. Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother. 2013;57(10):5104–5111. doi:10.1128/AAC.01230-1323917322
   PubMed Web of Science ®Google Scholar
• Grabein B, Graninger W, Rodriguez Bano J, Dinh A, Liesenfeld DB. Intravenous fosfomycin-back to the future. Systematic review and meta-analysis of the clinical literature. Clin Microbiol Infect. 2017;23(6):363–372. doi:10.1016/j.cmi.2016.12.00527956267
   PubMed Web of Science ®Google Scholar
• Sirijatuphat R, Thamlikitkul V. Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2014;58(9):5598–5601. doi:10.1128/AAC.02435-1324982065
   PubMed Web of Science ®Google Scholar
• Montravers P, Bassetti M. The ideal patient profile for new beta-lactam/beta-lactamase inhibitors. Curr Opin Infect Dis. 2018;31(6):587–593. doi:10.1097/QCO.000000000000049030299359
   PubMed Web of Science ®Google Scholar
• Lucasti C, Vasile L, Sandesc D, et al. Phase 2, Dose-Ranging Study of relebactam with imipenem-cilastatin in subjects with complicated intra-abdominal infection. Antimicrob Agents Chemother. 2016;60(10):6234–6243. doi:10.1128/AAC.00633-1627503659
   PubMed Web of Science ®Google Scholar
• Livermore DM, Warner M, Mushtaq S. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa. J Antimicrob Chemother. 2013;68(10):2286–2290. doi:10.1093/jac/dkt17823696619
   PubMed Web of Science ®Google Scholar
• Wright H, Bonomo RA, Paterson DL. New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn? Clin Microbiol Infect. 2017;23(10):704–712. doi:10.1016/j.cmi.2017.09.00128893690
   PubMed Web of Science ®Google Scholar
• Shields RK, Chen L, Cheng S, et al. Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant klebsiella pneumoniae infections. Antimicrob Agents Chemother. 2017;61(3).
   Web of Science ®Google Scholar
• Sun D, Rubio-Aparicio D, Nelson K, Dudley MN, Lomovskaya O. Meropenem-vaborbactam resistance selection, resistance prevention, and molecular mechanisms in mutants of KPC-producing klebsiella pneumoniae. Antimicrob Agents Chemother. 2017;61(12). doi:10.1128/AAC.01694-17
   Web of Science ®Google Scholar
• MacVane SH, Pandey R, Steed LL, Kreiswirth BN, Chen L. Emergence of ceftolozane-tazobactam-resistant pseudomonas aeruginosa during treatment is mediated by a single AmpC structural mutation. Antimicrob Agents Chemother. 2017;61(12). doi:10.1128/AAC.01183-17
   Web of Science ®Google Scholar
• Malik S, Kaminski M, Landman D, Quale J. Cefiderocol resistance in acinetobacter baumannii: roles of beta-lactamases, siderophore receptors, and penicillin binding protein 3. Antimicrob Agents Chemother. 2020;64(11). doi:10.1128/AAC.01221-20
   Web of Science ®Google Scholar
• Isler B, Doi Y, Bonomo RA, Paterson DL. New treatment options against carbapenem-resistant acinetobacter baumannii infections. Antimicrob Agents Chemother. 2019;63(1). doi:10.1128/AAC.01110-18
   Web of Science ®Google Scholar
• Bolarinwa OA. Principles and methods of validity and reliability testing of questionnaires used in social and health science researches. Niger Postgrad Med J. 2015;22(4):195–201. doi:10.4103/1117-1936.17395926776330
   PubMedGoogle Scholar
• Chiwaridzo M, Chikasha TN, Naidoo N, et al. Content validity and test-retest reliability of a low back pain questionnaire in Zimbabwean adolescents. Arch Physiother. 2017;7:3. doi:10.1186/s40945-017-0031-y29340198
   PubMedGoogle Scholar
• Talaat M, El-Shokry M, El-Kholy J, et al. National surveillance of health care-associated infections in Egypt: developing a sustainable program in a resource-limited country. Am J Infect Control. 2016;44(11):1296–1301. doi:10.1016/j.ajic.2016.04.21227339791
   PubMed Web of Science ®Google Scholar
• Moghnieh RA, Kanafani ZA, Tabaja HZ, Sharara SL, Awad LS, Kanj SS. Epidemiology of common resistant bacterial pathogens in the countries of the Arab League. Lancet Infect Dis. 2018;18(12):e379–e394. doi:10.1016/S1473-3099(18)30414-630292478
   PubMed Web of Science ®Google Scholar
• Talaat M, Kandeel A, Rasslan O, et al. Evolution of infection control in Egypt: achievements and challenges. Am J Infect Control. 2006;34(4):193–200. doi:10.1016/j.ajic.2005.05.02816679176
   PubMed Web of Science ®Google Scholar
• Talaat M, Saied T, Kandeel A, et al. A point prevalence survey of antibiotic use in 18 hospitals in Egypt. Antibiotics (Basel). 2014;3(3):450–460. doi:10.3390/antibiotics303045027025755
   PubMedGoogle Scholar
• Dahshan H, Abd-Elall AM, Megahed AM, Abd-El-Kader MA, Nabawy EE. Veterinary antibiotic resistance, residues, and ecological risks in environmental samples obtained from poultry farms, Egypt. Environ Monit Assess. 2015;187(2):2. doi:10.1007/s10661-014-4218-325600402
   PubMed Web of Science ®Google Scholar
• Kotb S, Lyman M, Ismail G, et al. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated infections surveillance data, 2011–2017. Antimicrob Resist Infect Control. 2020;9:2. doi:10.1186/s13756-019-0639-731911830
   PubMed Web of Science ®Google Scholar
• See I, Lessa FC, ElAta OA, et al. Incidence and pathogen distribution of healthcare-associated infections in pilot hospitals in Egypt. Infect Control Hosp Epidemiol. 2013;34(12):1281–1288. doi:10.1086/67398524225613
   PubMed Web of Science ®Google Scholar
• Abdulzahra AT, Khalil MAF, Elkhatib WF. First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt. New Microbes New Infect. 2018;26:53–58. doi:10.1016/j.nmni.2018.08.00730224972
   PubMedGoogle Scholar
• Al-Hassan L, El Mehallawy H, Amyes SG. Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt. Clin Microbiol Infect. 2013;19(11):1082–1088. doi:10.1111/1469-0691.1214323413888
   PubMed Web of Science ®Google Scholar
• Benmahmod AB, Said HS, Ibrahim RH. Prevalence and mechanisms of carbapenem resistance among acinetobacter baumannii clinical isolates in Egypt. Microb Drug Resist. 2019;25(4):480–488. doi:10.1089/mdr.2018.014130394846
   PubMed Web of Science ®Google Scholar
• El-Kholy AA, Elanany MG, Sherif MM, Gad MA. High prevalence of VIM, KPC, and NDM expression among surgical site infection pathogens in patients having emergency surgery. Surg Infect (Larchmt). 2018;19(6):629–633. doi:10.1089/sur.2018.08829979638
   PubMed Web of Science ®Google Scholar
• El-Sayed-Ahmed MA, Amin MA, Tawakol WM, Loucif L, Bakour S, Rolain JM. High prevalence of bla(NDM-1) carbapenemase-encoding gene and 16S rRNA armA methyltransferase gene among Acinetobacter baumannii clinical Isolates in Egypt. Antimicrob Agents Chemother. 2015;59(6):3602–3605. doi:10.1128/AAC.04412-1425801566
   PubMed Web of Science ®Google Scholar
• Fouad M, Attia AS, Tawakkol WM, Hashem AM. Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. Int J Infect Dis. 2013;17(12):e1252–1254. doi:10.1016/j.ijid.2013.07.01224084245
   PubMed Web of Science ®Google Scholar
• Makharita RR, El-Kholy I, Hetta HF, et al. Antibiogram and genetic characterization of carbapenem-resistant Gram-negative pathogens incriminated in healthcare-associated infections. Infect Drug Resist. 2020;13:3991–4002. doi:10.2147/IDR.S27697533177849
   PubMed Web of Science ®Google Scholar
• Nageeb W, Kamel M, Zakaria S, Metwally L. Phenotypic characterization of Acinetobacter baumannii isolates from intensive care units at a tertiary-care hospital in Egypt. East Mediterr Health J. 2014;20(3):203–211. doi:10.26719/2014.20.3.20324950079
   PubMed Web of Science ®Google Scholar
• Raouf M, Ghazal T, Kassem M, Agamya A, Amer A. Surveillance of surgical-site infections and antimicrobial resistance patterns in a tertiary hospital in Alexandria, Egypt. J Infect Dev Ctries. 2020;14(3):277–283. doi:10.3855/jidc.1212432235088
   PubMed Web of Science ®Google Scholar
• Sultan AM, Seliem WA. Identifying risk factors for healthcare-associated infections caused by carbapenem-resistant acinetobacter baumannii in a neonatal intensive care unit. Sultan Qaboos Univ Med J. 2018;18(1):e75–e80. doi:10.18295/squmj.2018.18.01.01229666685
   PubMedGoogle Scholar
• Basha AM, El-Sherbiny GM, Mabrouk MI. Phenotypic characterization of the Egyptian isolates “extensively drug-resistant Pseudomonas aeruginosa” and detection of their metallo-β-lactamases encoding genes. Bull Natl Res Cent. 2020;44:117. doi:10.1186/s42269-020-00350-8
   Google Scholar
• El-Mahdy R, El-Kannishy G. Virulence factors of carbapenem-resistant pseudomonas aeruginosa in hospital-acquired infections in Mansoura, Egypt. Infect Drug Resist. 2019;12:3455–3461. doi:10.2147/IDR.S22232931819540
   PubMed Web of Science ®Google Scholar
• Farhan SM, Ibrahim RA, Mahran KM, Hetta HF, Abd El-Baky RM. Antimicrobial resistance pattern and molecular genetic distribution of metallo-beta-lactamases producing Pseudomonas aeruginosa isolated from hospitals in Minia, Egypt. Infect Drug Resist. 2019;12:2125–2133. doi:10.2147/IDR.S19837331406468
   PubMed Web of Science ®Google Scholar
• Gaballah A, Elbaradei A, Elsheredy A, Kader O. Emergence of blaVEB and blaGES among VIM-producing Pseudomonas aeruginosa clinical isolates in Alexandria, Egypt. Acta Microbiol Immunol Hung. 2019;66(1):131–142. doi:10.1556/030.65.2018.04430403360
   PubMed Web of Science ®Google Scholar
• Hashem H, Hanora A, Abdalla S, Shawky A, Saad A. Carbapenem susceptibility and multidrug-resistance in pseudomonas aeruginosa isolates in Egypt. Jundishapur J Microbiol. 2016;9(11):e30257. doi:10.5812/jjm.3025728138370
   PubMed Web of Science ®Google Scholar
• Hashem H, Hanora A, Abdalla S, Shaeky A, Saad A. Dissemination of metallo-beta-lactamase in Pseudomonas aeruginosa isolates in Egypt: mutation in blaVIM-4. APMIS. 2017;125(5):499–505. doi:10.1111/apm.1266928295668
   PubMed Web of Science ®Google Scholar
• Khalifa HO, Soliman AM, Ahmed AM, et al. High carbapenem resistance in clinical Gram-negative pathogens isolated in Egypt. Microb Drug Resist. 2017;23(7):838–844. doi:10.1089/mdr.2015.033928191865
   PubMed Web of Science ®Google Scholar
• Zafer MM, Al-Agamy MH, El-Mahallawy HA, Amin MA, Ashour MS. Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients. Biomed Res Int. 2014;2014:101635. doi:10.1155/2014/10163524707471
   PubMed Web of Science ®Google Scholar
• ElMahallawy H, Zafer MM, Amin MA, Ragab MM, Al-Agamy MH. Spread of carbapenem resistant Enterobacteriaceae at tertiary care cancer hospital in Egypt. Infect Dis (Lond). 2018;50(7):560–564. doi:10.1080/23744235.2018.142882429373938
   PubMed Web of Science ®Google Scholar
• Helal SF, El-Rachidi NG, AbdulRahman EM, Hassan DM. The presence of blaKPC-mediated resistance in Enterobacteriaceae in Cairo University hospitals in Egypt and its correlation with in vitro carbapenem susceptibility. J Chemother. 2014;26(2):125–128. doi:10.1179/1973947813Y.000000009924592883
   PubMed Web of Science ®Google Scholar
• Kamel NA, El-Tayeb WN, El-Ansary MR, Mansour MT, Aboshanab KM. Phenotypic screening and molecular characterization of carbapenemase-producing Gram-negative bacilli recovered from febrile neutropenic pediatric cancer patients in Egypt. PLoS One. 2018;13(8):e0202119. doi:10.1371/journal.pone.020211930157188
   PubMed Web of Science ®Google Scholar
• Tawfick MM, Alshareef WA, Bendary HA, Elmahalawy H, Abdulall AK. The emergence of carbapenemase blaNDM genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patients. Eur J Clin Microbiol Infect Dis. 2020;39(7):1251–1259. doi:10.1007/s10096-020-03839-232062725
   PubMed Web of Science ®Google Scholar
• El-Badawy MF, El-Far SW, Althobaiti SS, Abou-Elazm FI, Shohayeb MM. The First Egyptian report showing the co-existence of bla NDM-25, bla OXA-23, bla OXA-181, and bla GES-1 among carbapenem-resistant K. pneumoniae clinical isolates genotyped by BOX-PCR. Infect Drug Resist. 2020;13:1237–1250. doi:10.2147/IDR.S24406432425561
   PubMed Web of Science ®Google Scholar
• ElMahallawy H, Zafer MM, Al-Agamy M, et al. Dissemination of ST101 blaOXA-48 producing Klebsiella pneumoniae at tertiary care setting. J Infect Dev Ctries. 2018;12(6):422–428. doi:10.3855/jidc.978931940293
   PubMed Web of Science ®Google Scholar
• Ghaith DM, Zafer MM, Said HM, et al. Genetic diversity of carbapenem-resistant Klebsiella Pneumoniae causing neonatal sepsis in intensive care unit, Cairo, Egypt. Eur J Clin Microbiol Infect Dis. 2020;39(3):583–591. doi:10.1007/s10096-019-03761-231773363
   PubMed Web of Science ®Google Scholar
• Khalil MAF, Elgaml A, El-Mowafy M. Emergence of multidrug-resistant New Delhi Metallo-beta-Lactamase-1-producing klebsiella pneumoniae in Egypt. Microb Drug Resist. 2017;23(4):480–487. doi:10.1089/mdr.2016.000327575913
   PubMed Web of Science ®Google Scholar
• Khalil MAF, Hager R, Abd-El Reheem F, et al. A Study of the Virulence Traits of carbapenem-resistant klebsiella pneumoniae Isolates in a Galleria mellonella model. Microb Drug Resist. 2019;25(7):1063–1071. doi:10.1089/mdr.2018.027031033413
   PubMed Web of Science ®Google Scholar
• Mohamed ER, Ali MY, Waly N, Halby HM, El-Baky RMA. The Inc FII plasmid and its contribution in the transmission of blaNDM-1 and blaKPC-2 in Klebsiella pneumoniae in Egypt. Antibiotics (Basel). 2019;8(4). doi:10.3390/antibiotics8040266
   PubMed Web of Science ®Google Scholar
• Ragheb SM, Tawfick MM, El-Kholy AA, Abdulall AK. Phenotypic and genotypic features of klebsiella pneumoniae harboring carbapenemases in Egypt: OXA-48-like carbapenemases as an investigated model. Antibiotics (Basel). 2020;9(12). doi:10.3390/antibiotics9120852
   Web of Science ®Google Scholar
• Wasfi R, Elkhatib WF, Ashour HM. Molecular typing and virulence analysis of multidrug resistant Klebsiella pneumoniae clinical isolates recovered from Egyptian hospitals. Sci Rep. 2016;6:38929. doi:10.1038/srep3892928004732
   PubMed Web of Science ®Google Scholar
• Abdallah HM, Wintermans BB, Reuland EA, et al. Extended-spectrum beta-lactamase- and carbapenemase-producing enterobacteriaceae isolated from Egyptian patients with suspected blood stream infection. PLoS One. 2015;10(5):e0128120. doi:10.1371/journal.pone.012812026001049
   PubMed Web of Science ®Google Scholar
• Bouchillon SK, Johnson BM, Hoban DJ, et al. Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002. Int J Antimicrob Agents. 2004;24(2):119–124. doi:10.1016/j.ijantimicag.2004.01.01015288309
   PubMed Web of Science ®Google Scholar
• Fam N, Leflon-Guibout V, Fouad S, et al. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb Drug Resist. 2011;17(1):67–73. doi:10.1089/mdr.2010.006321128836
   PubMed Web of Science ®Google Scholar
• Zafer MM, El-Mahallawy HA, Abdulhak A, Amin MA, Al-Agamy MH, Radwan HH. Emergence of colistin resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli strains isolated from cancer patients. Ann Clin Microbiol Antimicrob. 2019;18(1):40. doi:10.1186/s12941-019-0339-431831019
   PubMed Web of Science ®Google Scholar
• Abd-Elmonsef MME, Elsharawy D, Abd-Elsalam AS. Mechanical ventilator as a major cause of infection and drug resistance in intensive care unit. Environ Sci Pollut Res Int. 2018;25(31):30787–30792. doi:10.1007/s11356-017-8613-528233206
   PubMed Web of Science ®Google Scholar
• Awad HA, Mohamed MH, Badran NF, Mohsen M, Abd-Elrhman AS. Multidrug-resistant organisms in neonatal sepsis in two tertiary neonatal ICUs, Egypt. J Egypt Public Health Assoc. 2016;91(1):31–38. doi:10.1097/01.EPX.0000482038.76692.327110858
   PubMedGoogle Scholar
• El-Domany RA, Awadalla OA, Shabana SA, El-Dardir MA, Emara M. Analysis of the correlation between antibiotic resistance patterns and virulence determinants in pathogenic klebsiella pneumoniae isolates from Egypt. Microb Drug Resist. 2020. doi:10.1089/mdr.2020.0236
   Web of Science ®Google Scholar
• El-Kholy A, Saied T, Gaber M, et al. Device-associated nosocomial infection rates in intensive care units at Cairo University hospitals: first step toward initiating surveillance programs in a resource-limited country. Am J Infect Control. 2012;40(6):e216–220. doi:10.1016/j.ajic.2011.12.01022418610
   PubMed Web of Science ®Google Scholar
• Galal L, Abdel Aziz NA, Hassan WM. Defining the relationship between phenotypic and genotypic resistance profiles of multidrug-resistant enterobacterial clinical isolates. Adv Exp Med Biol. 2019;1214:9–21.29748922
   PubMed Web of Science ®Google Scholar
• Saied T, Elkholy A, Hafez SF, et al. Antimicrobial resistance in pathogens causing nosocomial bloodstream infections in university hospitals in Egypt. Am J Infect Control. 2011;39(9):e61–65. doi:10.1016/j.ajic.2011.04.00921835504
   PubMed Web of Science ®Google Scholar
• Talaat M, Hafez S, Saied T, Elfeky R, El-Shoubary W, Pimentel G. Surveillance of catheter-associated urinary tract infection in 4 intensive care units at Alexandria university hospitals in Egypt. Am J Infect Control. 2010;38(3):222–228. doi:10.1016/j.ajic.2009.06.01119837480
   PubMed Web of Science ®Google Scholar
• Abd El-Baky RM, Masoud SM, Mohamed DS, et al. Prevalence and some possible mechanisms of colistin resistance among multidrug-resistant and extensively drug-resistant pseudomonas aeruginosa. Infect Drug Resist. 2020;13:323–332. doi:10.2147/IDR.S23881132099423
   PubMed Web of Science ®Google Scholar
• Abdelaziz MO, Bonura C, Aleo A, Fasciana T, Cala C, Mammina C. Cephalosporin resistant Escherichia coli from cancer patients in Cairo, Egypt. Microbiol Immunol. 2013;57(5):391–395. doi:10.1111/1348-0421.1204623668612
   PubMed Web of Science ®Google Scholar
• Al-Agamy MHM, El-Din Ashour MS, Wiegand I. First description of CTX-M beta-lactamase-producing clinical Escherichia coli isolates from Egypt. Int J Antimicrob Agents. 2006;27(6):545–548. doi:10.1016/j.ijantimicag.2006.01.00716713187
   PubMed Web of Science ®Google Scholar
• El-Badawy MF, Tawakol WM, Maghrabi IA, Mansy MS, Shohayeb MM, Ashour MS. Iodometric and molecular detection of ESBL production among clinical isolates of E. coli fingerprinted by ERIC-PCR: the First Egyptian Report Declares the Emergence of E. coli O25b-ST131clone Harboring blaGES. Microb Drug Resist. 2017;23(6):703–717. doi:10.1089/mdr.2016.018128099061
   PubMed Web of Science ®Google Scholar
• Hassan WM, Hashim A, Domany R. Plasmid mediated quinolone resistance determinants qnr, aac(6ʹ)-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt. Indian J Med Microbiol. 2012;30(4):442–447. doi:10.4103/0255-0857.10376623183470
   PubMed Web of Science ®Google Scholar
• Abdulall AK, Tawfick MM, El Manakhly AR, El Kholy A. Carbapenem-resistant Gram-negative bacteria associated with catheter-related bloodstream infections in three intensive care units in Egypt. Eur J Clin Microbiol Infect Dis. 2018;37(9):1647–1652. doi:10.1007/s10096-018-3294-729936619
   PubMed Web of Science ®Google Scholar
• Abouelfetouh A, Torky AS, Aboulmagd E. Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt. Antimicrob Resist Infect Control. 2019;8:185. doi:10.1186/s13756-019-0611-631832185
   PubMed Web of Science ®Google Scholar
• Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AM, El Kholy A. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis. 2014;22:49–54. doi:10.1016/j.ijid.2013.12.00424607428
   PubMed Web of Science ®Google Scholar
• Alkasaby NM, El Sayed Zaki M. Molecular Study of Acinetobacter baumannii Isolates for Metallo-beta-Lactamases and extended-Spectrum-beta-Lactamases Genes in Intensive Care Unit, Mansoura University Hospital, Egypt. Int J Microbiol. 2017;2017:3925868. doi:10.1155/2017/392586828567057
   PubMed Web of Science ®Google Scholar
• El Bannah AMS, Nawar NN, Hassan RMM, Salem STB. Molecular epidemiology of carbapenem-resistant acinetobacter baumannii in a Tertiary Care Hospital in Egypt: clonal spread of blaOXA-23. Microb Drug Resist. 2018;24(3):269–277. doi:10.1089/mdr.2017.005728783427
   PubMed Web of Science ®Google Scholar
• Abaza AF, El Shazly SA, Selim HSA, Aly GSA. Metallo-Beta-Lactamase producing pseudomonas aeruginosa in a Healthcare setting in Alexandria, Egypt. Pol J Microbiol. 2017;66(3):297–308. doi:10.5604/01.3001.0010.485529319510
   PubMed Web of Science ®Google Scholar
• Abbas HA, El-Ganiny AM, Kamel HA. Phenotypic and genotypic detection of antibiotic resistance of Pseudomonas aeruginosa isolated from urinary tract infections. Afr Health Sci. 2018;18(1):11–21. doi:10.4314/ahs.v18i1.329977252
   PubMed Web of Science ®Google Scholar
• El Zowalaty ME, Gyetvai B. Effectiveness of antipseudomonal antibiotics and mechanisms of multidrug resistance in pseudomonas aeruginosa. Pol J Microbiol. 2016;65(1):23–32. doi:10.5604/17331331.119727227281991
   PubMed Web of Science ®Google Scholar
• El-Domany RA, Emara M, El-Magd MA, Moustafa WH, Abdeltwab NM. Emergence of imipenem-resistant pseudomonas aeruginosa clinical isolates from Egypt Coharboring VIM and IMP carbapenemases. Microb Drug Resist. 2017;23(6):682–686. doi:10.1089/mdr.2016.023428085553
   PubMed Web of Science ®Google Scholar
• El-Mahdy TS. Expression of ampC, oprD, and mexA, outer membrane protein analysis and carbapenemases in multidrug resistant clinical isolates of Pseudomonas aeruginosa from Egypt. J Chemother. 2014;26(6):379–381. doi:10.1179/1973947814Y.000000019524867184
   PubMed Web of Science ®Google Scholar
• Raouf MR, Sayed M, Rizk HA, Hassuna NA. High incidence of MBL-mediated imipenem resistance among Pseudomonas aeruginosa from surgical site infections in Egypt. J Infect Dev Ctries. 2018;12(7):520–525. doi:10.3855/jidc.993631954000
   PubMed Web of Science ®Google Scholar
• Soliman AM, Zarad HO, Nariya H, Shimamoto T, Shimamoto T. Genetic analysis of carbapenemase-producing Gram-negative bacteria isolated from a university teaching hospital in Egypt. Infect Genet Evol. 2020;77:104065. doi:10.1016/j.meegid.2019.10406531634643
   PubMed Web of Science ®Google Scholar
• Zafer MM, Al-Agamy MH, El-Mahallawy HA, Amin MA, El din ashour S. Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt. BMC Infect Dis. 2015;15:122. doi:10.1186/s12879-015-0861-825880997
   PubMed Web of Science ®Google Scholar
• Poirel L, Abdelaziz MO, Bernabeu S, Nordmann P. Occurrence of OXA-48 and VIM-1 carbapenemase-producing Enterobacteriaceae in Egypt. Int J Antimicrob Agents. 2013;41(1):90–91. doi:10.1016/j.ijantimicag.2012.08.01523040010
   PubMed Web of Science ®Google Scholar
• El-Kholy AA, Girgis SA, Shetta MAF, Abdel-Hamid DH, Elmanakhly AR. Molecular characterization of multidrug-resistant Gram-negative pathogens in three tertiary hospitals in Cairo, Egypt. Eur J Clin Microbiol Infect Dis. 2020;39(5):987–992. doi:10.1007/s10096-020-03812-z31953591
   PubMed Web of Science ®Google Scholar
• Helmy OM, Kashef MT. Different phenotypic and molecular mechanisms associated with multidrug resistance in Gram-negative clinical isolates from Egypt. Infect Drug Resist. 2017;10:479–498. doi:10.2147/IDR.S14719229263684
   PubMed Web of Science ®Google Scholar
• Ahmed SH, Daef EA, Badary MS, Mahmoud MA, Abd-Elsayed AA. Nosocomial blood stream infection in intensive care units at Assiut University Hospitals (Upper Egypt) with special reference to extended spectrum beta-lactamase producing organisms. BMC Res Notes. 2009;2:76. doi:10.1186/1756-0500-2-7619419535
   PubMedGoogle Scholar
• Azzab MM, El-Sokkary RH, Tawfeek MM, Gebriel MG. Multidrug-resistant bacteria among patients with ventilator associated pneumonia in an emergency intensive care unit, Egypt. East Mediterr Health J. 2016;22(12):894–903. doi:10.26719/2016.22.12.894
   Web of Science ®Google Scholar
• Hassuna NA, AbdelAziz RA, Zakaria A, Abdelhakeem M. Extensively-drug resistant Klebsiella pneumoniae recovered from neonatal sepsis cases from a major NICU in Egypt. Front Microbiol. 2020;11:1375. doi:10.3389/fmicb.2020.0137532636828
   PubMed Web of Science ®Google Scholar
• Metwally L, Gomaa N, Attallah M, Kamel N. High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt. East Mediterr Health J. 2013;19(11):947–952. doi:10.26719/2013.19.11.94724673086
   PubMed Web of Science ®Google Scholar